Article headline
Trends

Has Patanjali’s Coronil Been Certified By The WHO?

The World Health Organisation provided clarification and denied any association with endorsing the Coronil kit produced by Patanjali Ayurved

The ‘Coronil’ medicine made by Patanjali Ayurveda had previously raised massive questions over its efficiency to battle the coronavirus. Launched on June 23rd last year during the peak of the pandemic, the company faced severe backlash due to the absence of any scientific evidence related to the efficacy of the medicinal kit. During this wave of criticism, the Ayush ministry had declared it to be an "Immuno booster".

However, recently it has made it to the news with a different controversial claim.

Even though approved by the AYUSH ministry, during the launch event of the ‘Coronil Kit’ Patanjali in a statement claimed that“Coronil has received the Certificate of Pharmaceutical Product (CoPP) from the Ayush section of Central Drugs Standard Control Organisation as per the WHO certification scheme.”

The company further went on to state that with the Certificate of Pharmaceutical Product (CoPP), Coronil can be exported to 158 countries. It also stated that Coronil was recognized as a “supporting measure in Covid-19” by the Ayush Ministry

However, this statement by Patanjali was proven incorrect, when the World Health Organisation provided clarification on the treatment of novel coronavirus through traditional medicines. Thus, in a way WHO denied any association with endorsing the Coronil kit.

Through a tweet, the WHO’s regional office for South-East Asia on its official handle posted that “@WHO has not reviewed or certified the effectiveness of any traditional medicine for the treatment #Covid19.”

As a response to this tweet by WHO, the managing director of Patanjali Ayurveda, Acharya Balkrishna, also tweeted and stated that the Goods Manufacturing Practice (GMP) compliant Certificate of Pharmaceutical Product (CPP) to Coronil has been issued by the Drugs Controller General of India (DCGI), as per previous reports.

His tweet added, “It is clear that WHO does not approve or disapprove any drugs,” Balkrishna’s tweet added. He also reinstated that Patanjali was "clarifying to avoid confusion."

Further, on Friday, Patanjali had claimed that its Coronil is the first of its kind 'evidence-based medicine that can protect people from coronavirus. The launch of this medicine was conducted in the presence of Patanjali Ayurved promoter Baba Ramdev., where union health minister Harsh Vardhan and transport minister Nitin Gadkari were also a part of the event.

Ramdev Baba stated, "Study on the impact of Coronil on COVID has already been published in leading journals." "It would work not only for treatment, prevention and cure of COVID but also help in after-effects", he further added. The medicine was also claimed to function against asymptomatic, symptomatic and severe (cases).

However, based on WHO sources, Live Mint reported, “Furthermore, in a solidarity trial's interim results, published in October last year, it was found that all four treatments evaluated - remdesivir, hydroxychloroquine, lopinavir/ritonavir, and interferon - had little or no effect on overall mortality, initiation of ventilation and duration of hospital stay in hospitalized patients.”

Trends

Has Patanjali’s Coronil Been Certified By The WHO?

The World Health Organisation provided clarification and denied any association with endorsing the Coronil kit produced by Patanjali Ayurved

The ‘Coronil’ medicine made by Patanjali Ayurveda had previously raised massive questions over its efficiency to battle the coronavirus. Launched on June 23rd last year during the peak of the pandemic, the company faced severe backlash due to the absence of any scientific evidence related to the efficacy of the medicinal kit. During this wave of criticism, the Ayush ministry had declared it to be an "Immuno booster".

However, recently it has made it to the news with a different controversial claim.

Even though approved by the AYUSH ministry, during the launch event of the ‘Coronil Kit’ Patanjali in a statement claimed that“Coronil has received the Certificate of Pharmaceutical Product (CoPP) from the Ayush section of Central Drugs Standard Control Organisation as per the WHO certification scheme.”

The company further went on to state that with the Certificate of Pharmaceutical Product (CoPP), Coronil can be exported to 158 countries. It also stated that Coronil was recognized as a “supporting measure in Covid-19” by the Ayush Ministry

However, this statement by Patanjali was proven incorrect, when the World Health Organisation provided clarification on the treatment of novel coronavirus through traditional medicines. Thus, in a way WHO denied any association with endorsing the Coronil kit.

Through a tweet, the WHO’s regional office for South-East Asia on its official handle posted that “@WHO has not reviewed or certified the effectiveness of any traditional medicine for the treatment #Covid19.”

As a response to this tweet by WHO, the managing director of Patanjali Ayurveda, Acharya Balkrishna, also tweeted and stated that the Goods Manufacturing Practice (GMP) compliant Certificate of Pharmaceutical Product (CPP) to Coronil has been issued by the Drugs Controller General of India (DCGI), as per previous reports.

His tweet added, “It is clear that WHO does not approve or disapprove any drugs,” Balkrishna’s tweet added. He also reinstated that Patanjali was "clarifying to avoid confusion."

Further, on Friday, Patanjali had claimed that its Coronil is the first of its kind 'evidence-based medicine that can protect people from coronavirus. The launch of this medicine was conducted in the presence of Patanjali Ayurved promoter Baba Ramdev., where union health minister Harsh Vardhan and transport minister Nitin Gadkari were also a part of the event.

Ramdev Baba stated, "Study on the impact of Coronil on COVID has already been published in leading journals." "It would work not only for treatment, prevention and cure of COVID but also help in after-effects", he further added. The medicine was also claimed to function against asymptomatic, symptomatic and severe (cases).

However, based on WHO sources, Live Mint reported, “Furthermore, in a solidarity trial's interim results, published in October last year, it was found that all four treatments evaluated - remdesivir, hydroxychloroquine, lopinavir/ritonavir, and interferon - had little or no effect on overall mortality, initiation of ventilation and duration of hospital stay in hospitalized patients.”

Trends

Has Patanjali’s Coronil Been Certified By The WHO?

The World Health Organisation provided clarification and denied any association with endorsing the Coronil kit produced by Patanjali Ayurved

The ‘Coronil’ medicine made by Patanjali Ayurveda had previously raised massive questions over its efficiency to battle the coronavirus. Launched on June 23rd last year during the peak of the pandemic, the company faced severe backlash due to the absence of any scientific evidence related to the efficacy of the medicinal kit. During this wave of criticism, the Ayush ministry had declared it to be an "Immuno booster".

However, recently it has made it to the news with a different controversial claim.

Even though approved by the AYUSH ministry, during the launch event of the ‘Coronil Kit’ Patanjali in a statement claimed that“Coronil has received the Certificate of Pharmaceutical Product (CoPP) from the Ayush section of Central Drugs Standard Control Organisation as per the WHO certification scheme.”

The company further went on to state that with the Certificate of Pharmaceutical Product (CoPP), Coronil can be exported to 158 countries. It also stated that Coronil was recognized as a “supporting measure in Covid-19” by the Ayush Ministry

However, this statement by Patanjali was proven incorrect, when the World Health Organisation provided clarification on the treatment of novel coronavirus through traditional medicines. Thus, in a way WHO denied any association with endorsing the Coronil kit.

Through a tweet, the WHO’s regional office for South-East Asia on its official handle posted that “@WHO has not reviewed or certified the effectiveness of any traditional medicine for the treatment #Covid19.”

As a response to this tweet by WHO, the managing director of Patanjali Ayurveda, Acharya Balkrishna, also tweeted and stated that the Goods Manufacturing Practice (GMP) compliant Certificate of Pharmaceutical Product (CPP) to Coronil has been issued by the Drugs Controller General of India (DCGI), as per previous reports.

His tweet added, “It is clear that WHO does not approve or disapprove any drugs,” Balkrishna’s tweet added. He also reinstated that Patanjali was "clarifying to avoid confusion."

Further, on Friday, Patanjali had claimed that its Coronil is the first of its kind 'evidence-based medicine that can protect people from coronavirus. The launch of this medicine was conducted in the presence of Patanjali Ayurved promoter Baba Ramdev., where union health minister Harsh Vardhan and transport minister Nitin Gadkari were also a part of the event.

Ramdev Baba stated, "Study on the impact of Coronil on COVID has already been published in leading journals." "It would work not only for treatment, prevention and cure of COVID but also help in after-effects", he further added. The medicine was also claimed to function against asymptomatic, symptomatic and severe (cases).

However, based on WHO sources, Live Mint reported, “Furthermore, in a solidarity trial's interim results, published in October last year, it was found that all four treatments evaluated - remdesivir, hydroxychloroquine, lopinavir/ritonavir, and interferon - had little or no effect on overall mortality, initiation of ventilation and duration of hospital stay in hospitalized patients.”

WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO
WATCH VIDEO